Maria Fernanda Braggion-Santos1, Dirk Lossnitzer2, Sebastian Buss2, Stephanie Lehrke3, Andreas Doesch2, Evangelos Giannitsis2, Grigorios Korosoglou2, Hugo A Katus2, Henning Steen4. 1. Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany School of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil. 2. Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. 3. Institut für Diagnostische und Interventionelle Radiologie/Neuroradiologie, DIAKO Flensburg, Flensburg, Germany. 4. Department of Cardiology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany henning.steen@gmx.de.
Abstract
AIMS: Cardiac allograft vasculopathy (CAV), which limits long-term survival after heart transplantation (HTX), is usually evaluated by coronary angiography (CA). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is a non-invasive technique that can detect CAV-related myocardial infarctions. We aimed to investigate the presence of LGE infarct-typical patterns in a large sample of HTX recipients and to correlate these findings with the severity of CAV assessed by CA. METHODS AND RESULTS: LGE-CMR was performed in 132 HTX patients on a 1.5-T MRI scanner (Philips, Best, the Netherlands). Infarct-typical LGE areas were identified as bright lesions with subendocardial involvement. Infarct-atypical LGE was classified as follows: (i) right ventricle (RV) insertion, (ii) intramural, (iii) epicardial, and (iv) diffuse. CA was performed for the assessment of CAV (CAV0 = no lesion, CAV1 = mild lesions, CAV2 = moderate lesions, CAV3 = severe lesions, or mild/moderate lesions with allograft dysfunction). Infarct-typical LGE patterns were detected in 29 (22%) patients distributed in all groups and they were already present in nearly every fifth CAV0 patient, increasing significantly among CAV groups (CAV0 = 19%, CAV1 = 10%, CAV2 = 36%, and CAV3 = 71%; P < 0.01). CONCLUSION: LGE-CMR was useful to identify myocardial scar possibly related to early CAV in a significant proportion of HTX recipients, otherwise classified as low-risk patients based on CA. Therefore, LGE-CMR could be helpful to intensify CAV monitoring, medical therapy, and clinical risk stratification. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Cardiac allograft vasculopathy (CAV), which limits long-term survival after heart transplantation (HTX), is usually evaluated by coronary angiography (CA). Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is a non-invasive technique that can detect CAV-related myocardial infarctions. We aimed to investigate the presence of LGE infarct-typical patterns in a large sample of HTX recipients and to correlate these findings with the severity of CAV assessed by CA. METHODS AND RESULTS: LGE-CMR was performed in 132 HTX patients on a 1.5-T MRI scanner (Philips, Best, the Netherlands). Infarct-typical LGE areas were identified as bright lesions with subendocardial involvement. Infarct-atypical LGE was classified as follows: (i) right ventricle (RV) insertion, (ii) intramural, (iii) epicardial, and (iv) diffuse. CA was performed for the assessment of CAV (CAV0 = no lesion, CAV1 = mild lesions, CAV2 = moderate lesions, CAV3 = severe lesions, or mild/moderate lesions with allograft dysfunction). Infarct-typical LGE patterns were detected in 29 (22%) patients distributed in all groups and they were already present in nearly every fifth CAV0 patient, increasing significantly among CAV groups (CAV0 = 19%, CAV1 = 10%, CAV2 = 36%, and CAV3 = 71%; P < 0.01). CONCLUSION: LGE-CMR was useful to identify myocardial scar possibly related to early CAV in a significant proportion of HTX recipients, otherwise classified as low-risk patients based on CA. Therefore, LGE-CMR could be helpful to intensify CAV monitoring, medical therapy, and clinical risk stratification. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Otavio Rizzi Coelho-Filho; Ravi Shah; Carlos Fernando Ramos Lavagnoli; Jose Carlos Barros; Tomas G Neilan; Venkatesh L Murthy; Pedro Paulo Martins de Oliveira; Jose Roberto Matos Souza; Elaine Soraya Barbosa de Oliveira Severino; Karlos Alexandre de Souza Vilarinho; Lindemberg da Mota Silveira Filho; Jose Garcia; Marc J Semigran; Otavio Rizzi Coelho; Michael Jerosch-Herold; Orlando Petrucci Journal: Int J Cardiovasc Imaging Date: 2016-07-20 Impact factor: 2.357
Authors: Akhil Narang; John E Blair; Mita B Patel; Victor Mor-Avi; Savitri E Fedson; Nir Uriel; Roberto M Lang; Amit R Patel Journal: Int J Cardiovasc Imaging Date: 2018-05-04 Impact factor: 2.357
Authors: Dietrich Beitzke; Alice Wielandner; Tim Wollenweber; Chrysoula Vraka; Verena Pichler; Keziban Uyanik-Uenal; Andreas Zuckermann; Andreas Greiser; Marcus Hacker; Christian Loewe Journal: J Magn Reson Imaging Date: 2019-03-20 Impact factor: 4.813
Authors: Lukas Stoiber; Felix Schoenrath; Christoph Knosalla; Hendrik Milting; Karin Klingel; Carsten Tschöpe; Radu Tanacli; Rolf Gebker; Alexander Berger; Burkert Pieske; Sebastian Kelle Journal: Front Immunol Date: 2021-02-22 Impact factor: 7.561